Criteria for inpatient diagnostic and treatment of patients with lung cancer, mesothelioma or thymoma
Pneumologie. 2024 Apr;78(4):e1. doi: 10.1055/a-2278-4661. Epub 2024 Feb 28.NO ABSTRACTPMID:38608660 | DOI:10.1055/a-2278-4661 (Source: Pneumologie)
Source: Pneumologie - April 12, 2024 Category: Respiratory Medicine Authors: Nikolaj Frost Claas Wesseler Bernhard W örmann Wilfried Ernst Erich Eberhardt Source Type: research
Criteria for inpatient diagnostic and treatment of patients with lung cancer, mesothelioma or thymoma
Pneumologie. 2024 Apr;78(4):233-235. doi: 10.1055/a-2227-3775. Epub 2024 Jan 4.NO ABSTRACTPMID:38608657 | DOI:10.1055/a-2227-3775 (Source: Pneumologie)
Source: Pneumologie - April 12, 2024 Category: Respiratory Medicine Authors: Nikolaj Frost Claas Wesseler Bernhard W örmann Wilfried Ernst Erich Eberhardt Source Type: research
YAP/TAZ-TEAD signalling axis: A new therapeutic target in malignant pleural mesothelioma
J Cell Mol Med. 2024 Apr;28(8):e18330. doi: 10.1111/jcmm.18330.ABSTRACTThe Hippo signalling pathway, a highly conserved signalling cassette, regulates organ size by controlling cell growth, apoptosis and stem cell self-renewal. The tumourigenic potential of this pathway is largely attributed to the activity of YAP/TAZ, which activate the TEAD1-4 transcription factors, leading to the expression of genes involved in cell proliferation and suppression of cell death. Aberrant regulation of the YAP/TAZ-TEAD signalling axis is commonly observed in malignant pleural mesothelioma (MPM), an insidious neoplasm of the pleural tissue ...
Source: Molecular Medicine - April 12, 2024 Category: Molecular Biology Authors: Kostas A Papavassiliou Amalia A Sofianidi Athanasios G Papavassiliou Source Type: research
Criteria for inpatient diagnostic and treatment of patients with lung cancer, mesothelioma or thymoma
Pneumologie. 2024 Apr;78(4):e1. doi: 10.1055/a-2278-4661. Epub 2024 Feb 28.NO ABSTRACTPMID:38608660 | DOI:10.1055/a-2278-4661 (Source: Pneumologie)
Source: Pneumologie - April 12, 2024 Category: Respiratory Medicine Authors: Nikolaj Frost Claas Wesseler Bernhard W örmann Wilfried Ernst Erich Eberhardt Source Type: research
Criteria for inpatient diagnostic and treatment of patients with lung cancer, mesothelioma or thymoma
Pneumologie. 2024 Apr;78(4):233-235. doi: 10.1055/a-2227-3775. Epub 2024 Jan 4.NO ABSTRACTPMID:38608657 | DOI:10.1055/a-2227-3775 (Source: Pneumologie)
Source: Pneumologie - April 12, 2024 Category: Respiratory Medicine Authors: Nikolaj Frost Claas Wesseler Bernhard W örmann Wilfried Ernst Erich Eberhardt Source Type: research
Criteria for inpatient diagnostic and treatment of patients with lung cancer, mesothelioma or thymoma
Pneumologie. 2024 Apr;78(4):e1. doi: 10.1055/a-2278-4661. Epub 2024 Feb 28.NO ABSTRACTPMID:38608660 | DOI:10.1055/a-2278-4661 (Source: Pneumologie)
Source: Pneumologie - April 12, 2024 Category: Respiratory Medicine Authors: Nikolaj Frost Claas Wesseler Bernhard W örmann Wilfried Ernst Erich Eberhardt Source Type: research
Criteria for inpatient diagnostic and treatment of patients with lung cancer, mesothelioma or thymoma
Pneumologie. 2024 Apr;78(4):233-235. doi: 10.1055/a-2227-3775. Epub 2024 Jan 4.NO ABSTRACTPMID:38608657 | DOI:10.1055/a-2227-3775 (Source: Pneumologie)
Source: Pneumologie - April 12, 2024 Category: Respiratory Medicine Authors: Nikolaj Frost Claas Wesseler Bernhard W örmann Wilfried Ernst Erich Eberhardt Source Type: research
YAP/TAZ-TEAD signalling axis: A new therapeutic target in malignant pleural mesothelioma
J Cell Mol Med. 2024 Apr;28(8):e18330. doi: 10.1111/jcmm.18330.ABSTRACTThe Hippo signalling pathway, a highly conserved signalling cassette, regulates organ size by controlling cell growth, apoptosis and stem cell self-renewal. The tumourigenic potential of this pathway is largely attributed to the activity of YAP/TAZ, which activate the TEAD1-4 transcription factors, leading to the expression of genes involved in cell proliferation and suppression of cell death. Aberrant regulation of the YAP/TAZ-TEAD signalling axis is commonly observed in malignant pleural mesothelioma (MPM), an insidious neoplasm of the pleural tissue ...
Source: J Cell Mol Med - April 12, 2024 Category: Molecular Biology Authors: Kostas A Papavassiliou Amalia A Sofianidi Athanasios G Papavassiliou Source Type: research
Criteria for inpatient diagnostic and treatment of patients with lung cancer, mesothelioma or thymoma
Pneumologie. 2024 Apr;78(4):e1. doi: 10.1055/a-2278-4661. Epub 2024 Feb 28.NO ABSTRACTPMID:38608660 | DOI:10.1055/a-2278-4661 (Source: Pneumologie)
Source: Pneumologie - April 12, 2024 Category: Respiratory Medicine Authors: Nikolaj Frost Claas Wesseler Bernhard W örmann Wilfried Ernst Erich Eberhardt Source Type: research
Criteria for inpatient diagnostic and treatment of patients with lung cancer, mesothelioma or thymoma
Pneumologie. 2024 Apr;78(4):233-235. doi: 10.1055/a-2227-3775. Epub 2024 Jan 4.NO ABSTRACTPMID:38608657 | DOI:10.1055/a-2227-3775 (Source: Pneumologie)
Source: Pneumologie - April 12, 2024 Category: Respiratory Medicine Authors: Nikolaj Frost Claas Wesseler Bernhard W örmann Wilfried Ernst Erich Eberhardt Source Type: research
Criteria for inpatient diagnostic and treatment of patients with lung cancer, mesothelioma or thymoma
Pneumologie. 2024 Apr;78(4):e1. doi: 10.1055/a-2278-4661. Epub 2024 Feb 28.NO ABSTRACTPMID:38608660 | DOI:10.1055/a-2278-4661 (Source: Pneumologie)
Source: Pneumologie - April 12, 2024 Category: Respiratory Medicine Authors: Nikolaj Frost Claas Wesseler Bernhard W örmann Wilfried Ernst Erich Eberhardt Source Type: research
Criteria for inpatient diagnostic and treatment of patients with lung cancer, mesothelioma or thymoma
Pneumologie. 2024 Apr;78(4):233-235. doi: 10.1055/a-2227-3775. Epub 2024 Jan 4.NO ABSTRACTPMID:38608657 | DOI:10.1055/a-2227-3775 (Source: Pneumologie)
Source: Pneumologie - April 12, 2024 Category: Respiratory Medicine Authors: Nikolaj Frost Claas Wesseler Bernhard W örmann Wilfried Ernst Erich Eberhardt Source Type: research
Criteria for inpatient diagnostic and treatment of patients with lung cancer, mesothelioma or thymoma
Pneumologie. 2024 Apr;78(4):e1. doi: 10.1055/a-2278-4661. Epub 2024 Feb 28.NO ABSTRACTPMID:38608660 | DOI:10.1055/a-2278-4661 (Source: Pneumologie)
Source: Pneumologie - April 12, 2024 Category: Respiratory Medicine Authors: Nikolaj Frost Claas Wesseler Bernhard W örmann Wilfried Ernst Erich Eberhardt Source Type: research
Criteria for inpatient diagnostic and treatment of patients with lung cancer, mesothelioma or thymoma
Pneumologie. 2024 Apr;78(4):233-235. doi: 10.1055/a-2227-3775. Epub 2024 Jan 4.NO ABSTRACTPMID:38608657 | DOI:10.1055/a-2227-3775 (Source: Pneumologie)
Source: Pneumologie - April 12, 2024 Category: Respiratory Medicine Authors: Nikolaj Frost Claas Wesseler Bernhard W örmann Wilfried Ernst Erich Eberhardt Source Type: research
Diagnostic performance of immunohistochemistry markers for malignant pleural mesothelioma diagnosis and subtypes. A systematic review and meta-analysis
CONCLUSION: Immunohistochemistry markers are essential in accurately diagnosing malignant pleural mesothelioma and its histological subtypes. This systematic review and meta-analysis provide a comprehensive insight into the diagnostic performance of these markers, facilitating their potential clinical utility in the discrimination of malignant pleural mesothelioma from other pleural pathologies and the differentiation of malignant pleural mesothelioma subtypes.PMID:38603842 | DOI:10.1016/j.prp.2024.155276 (Source: Pathology, Research and Practice)
Source: Pathology, Research and Practice - April 11, 2024 Category: Pathology Authors: Rafael Parra-Medina Juan Pablo Casta ñeda-González Viviana Chaves-Cabezas Juan Pablo Alzate Juan Jos é Chaves Source Type: research
